Prevalence and complication of COVID-19 in patients with ankylosing spondylitis (AS) and its relationship with TNF-a inhibitors.
Shafieh MovassaghiSeyed Ahmad Seyed AlinaghiAbdolrahman RostamianSeyed Reza NajafizadehElham NezhadseifiPublished in: Immunity, inflammation and disease (2023)
The use of the TNF-α inhibitors in patients with AS, may be associated with reduced hospitalization and death rate in COVID-19 cases.